Skip to main content
. 2016 Mar 17;11(3):e0151785. doi: 10.1371/journal.pone.0151785

Fig 2. Representative immunostaining showing examples of prostate tumors with (A) negative staining intensity, (B) weak staining intensity, and (C) moderate staining intensity.

Fig 2